Viewing Study NCT07277660


Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2026-05-29 @ 10:16 PM
Study NCT ID: NCT07277660
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-11
First Post: 2025-12-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis
Sponsor: UCB Biopharma SRL
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atopic Dermatitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Atopic Dermatitis View
None Galvokimig, View
None UCB9741 View